聚合酵素鏈鎖反應(PCR)系統的全球市場 - 市場規模(各市場區隔)，佔有率，法規，償付，預測(～2033年)

本報告提供全球聚合酵素鏈鎖反應(PCR)系統市場相關調查分析，提供主要企業與市場佔有率，主要趨勢，創新的產品與技術，競爭情形等資訊。

市場模式的主要內容如下列。

已上市的聚合酵素鏈鎖反應(PCR)系統與不斷變化的競爭格局

• 主要的產業趨勢考察
• 按聚合酵素鏈鎖反應(PCR)系統市場區隔的年度收益與市場預測(2015年～2033年)
• 台數，平均銷售價格，市場金額相關市場層級的資料

世界，地區，國家層級的市場固有考察

• 各地區分類的全球趨勢之特定市場定性資訊和國家/地區考察
• 聚合酵素鏈鎖反應(PCR)系統市場SWOT分析
• 聚合酵素鏈鎖反應(PCR)系統市場競爭動態的考察和趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規形勢

對象企業

• Cepheid Inc
• Bio-Rad Laboratories Inc
• Thermo Fisher Scientific Inc
• Qiagen NV
• Abbott Laboratories
• bioMerieux Inc
• Becton Dickinson and Co
• Siemens Healthineers AG
• Roche Diagnostics International Ltd
• Standard BioTools Inc
• Hologic Inc
• 其他

Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

The Polymerase chain reaction (PCR) is a method used to amplify and analyze short DNA (or RNA) sequences in a sample with small quantities of RNA or DNA, through repeated heating and cooling of nucleic acids, combined with recombinant enzymes, to mimic the natural process used in cells to repair DNA. PCR amplifies the selected sequence of DNA segments producing millions of copies within a few hours. Quantitative PCR (qPCR) is a modification of the technique that allows measurement of the amplified RNA or DNA.

Polymerase Chain Reaction (PCR) Systems are instruments used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. The Polymerase Chain Reaction (PCR) System tracks the essential equipment only, and not accessories and/or additional costs associated with PCR System installation.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Polymerase Chain Reaction (PCR) Systems and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Polymerase Chain Reaction (PCR) Systems market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Polymerase Chain Reaction (PCR) Systems market.
• Competitive dynamics insights and trends provided for Polymerase Chain Reaction (PCR) Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cepheid Inc, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Qiagen NV, Abbott Laboratories, bioMerieux Inc, Becton Dickinson and Co, Siemens Healthineers AG, Roche Diagnostics International Ltd, Standard BioTools Inc, Hologic Inc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the PCR Systems market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Polymerase Chain Reaction (PCR) Systems market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Polymerase Chain Reaction (PCR) Systems market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Polymerase Chain Reaction (PCR) Systems market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.